| Factor Information | |
|---|---|
| Data ID | 667 |
| Factor | BAV post aortic valve replacement (AVR) |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | adult with BAV post aortic valve replacement |
| Conclusion | BAVs with a higher incidence of IE in those post aortic valve replacement (AVR) compared to those without. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 22 |
| CHD Type | isolated CHD |
| CHD Subtype | BAV |
| Reference | |
|---|---|
| PMID | 29121720 |
| Year | 2017 |
| Title | Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | Australia,Sydney | |
| Method | Univariate and multivariate analyses | |
| Race | Australian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | with AVR(Treatment) | without AVR(Control) |
| Number | 10 | 23 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 10/135 | 23/483 |
